The current financial score of Medpace Holdings Inc is 8.85. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 707.33M, representing a year-over-year increase of 17.24%, while its net profit experienced a year-over-year increase of 34.46%.
The current valuation score of Medpace Holdings Inc is 9.87. Its current P/E ratio is 38.25, which is 17.47% below the recent high of 44.93 and 46.34% above the recent low of 20.52.
The current earnings forecast score of Medpace Holdings Inc is 6.14. The average price target is 568.83, with a high of 692.00 and a low of 377.81.
The current price momentum score of Medpace Holdings Inc is 3.00. Currently, the stock price is trading between the resistance level at 640.90 and the support level at 588.85, making it suitable for range-bound swing trading.
The current institutional shareholding score of Medpace Holdings Inc is 7.00. The latest institutional shareholding proportion is 85.88%, representing a quarter-over-quarter decrease of 1.23%.
The current risk assessment score of Medpace Holdings Inc is 6.80. The company's beta value is 1.19. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.